Formulas marketed for toddlers are a burgeoning business, but pediatricians have long recommended against their use.

and is promoted as the next stage in child nutrition – all in an attempt to convince parents and caregivers to buy a product toddlers don’t need.” Abbott Laboratories is purposefully ...

Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products. It operates through the following business segments: Established Pharmaceutical Products ...

The organization that filed the proposed class action alleges marketing for the product tricks parents of young children who ...

"Abbott Laboratories began its 125th year with approximately ... "For our shareholders, we are developing the kind of essential, life-enhancing products that will ensure the enduring growth ...

Abbott Laboratories will report earnings pre-market on January 22, with an earnings consensus of $1.04 per share. See why I ...

Abbott Laboratories is being sued over how it pitches such products. Abbott, a health care products conglomerate based in Illinois, is misleading parents and other caregivers about the nutritional ...

During this period, the Zacks Medical - Products industry, which Abbott falls in, has lost 0.6%. The key question now is: What could be the stock's future direction? While media releases or rumors ...

Abbott Laboratories ABT shares are trading at a discount to the Zacks Medical Products industry. Its trailing 12-month price-to-book value of 4.91X is significantly lower than the industry average ...

Abbott Laboratories (NYSE:ABT – Get Free Report) was the recipient of unusually large options trading activity on Tuesday. Stock traders bought 71,494 call options on the company. This is an increase ...